Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q2 2022 call → NOWe need answer YES/NO based on transcript. Need analyze if management explains momentum/trajectory by pointing to wave of new building/equipping/capacity-creation by other parties (customers, etc.) for which company supplies part, and conveys early/intensifying. Transcript: Surgery Partners operates surgical facilities (ASCs). They discuss their own growth, physician recruiting, acquisitions, de novos. They mention "transition of procedures out of traditional acute care inpatient settings continues to accelerate." They talk about joint replacements, cardiac procedures. They mention "preparing for the next wave in procedures that we expect to migrate to outpatient settings." They discuss "increasing share of orthopedic and cardiac procedures moving into lower cost, high quality, short-stay surgical facilities." They are considering options to capture share including robotics, renovation, M&A, de novo. They mention ValueHealth partnership, de novos. But is this about OTHERS building new capacity? The company itself is building/acquiring facilities. The "wave" is procedures migrating from hospitals to ASCs. That is a shift in site of care, not necessarily others building new capacity. The company is the one building/expanding its own facilities. They mention "in-market development of de novo facilities is a core strategic growth pillar." That's their own capacity. They also mention "physician recruiting" - physicians are not building capacity. They mention "new physician recruiting efforts yielded 100 new recruits" - that's adding physicians to their facilities, not others building. Question asks: Does management explain momentum by pointing to A WAVE OF NEW BUILDING, EQUIPPING, OR CAPACITY-CREATION BEING UNDERTAKEN BY OTHER PARTIES — its customers, its customers' customers, or institutions in its end markets — for which the company already supplies part of what those parties must buy? Here, the company is a provider of surgical services. Its customers are patients, physicians, payers. Are others building? Maybe hospitals? No. The "transition of procedures out of acute care" means hospitals losing volume, not building. The company is building its own ASCs. That's own capacity expansion, not others. Also, the company supplies services, not equipment to others. So answer NO. Need ensure no other interpretation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.